@biomaxxer's fountain of youth peptide claims, fact-checked
Quick answer
This video promotes a multi-compound anti-aging protocol combining topical retinoids, injectable or topical peptides (GHK-Cu), NAD+ precursors (NMN), carotenoids, MT2, and antioxidants. At least two compounds named in the video (Caesaretin, Hidilon) cannot be verified in any pharmacological or peptide database, and one compound (MT2) is mischaracterized as a carotenoid when it is a synthetic melanocortin agonist with a distinct and not fully characterized safety profile. Telomerase activation via intranasal administration of an unidentifiable compound is presented without any supporting citation and conflicts with existing oncology literature on telomerase upregulation risks.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @biomaxxer actually say?
The creator laid out a multi-compound "anti-aging stack" that included topical retinoids, GHK-Cu peptide, carotenoids, MT2 (melanotan II), NMN, something called "Hidilon" taken intranasally for telomerase activation, and antioxidants like NAD+, glutathione, and high-dose melatonin. The pitch was simple: do all this and "gear will not age you if leveraged correctly."
That last line is doing a lot of work. The stack mixes compounds with legitimate peer-reviewed support, compounds with early but not conclusive evidence, and at least one that is either misspelled beyond recognition or outright made up. The framing is confident in a way the science is not.
A few product names were mangled badly enough to cause real confusion. "Caesaretin" is not a recognized retinoid in dermatology or pharmacology literature. "Beta carotenein" is not standard nomenclature. And "Hidilon" does not correspond to any known peptide, drug, or supplement in indexed databases.
Does the science back this up?
Parts of it, yes. The retinoid claim has decades of support. The GHK-Cu peptide data is genuinely interesting, though mostly in vitro. The carotenoid and antioxidant claims have real but modest evidence. The telomerase claim, however, is where this goes off the rails fast.
Tretinoin (the actual drug name) has strong RCT-level evidence for improving photoaged skin, stimulating collagen synthesis, and increasing epidermal cell turnover (Kang et al., 1995, Journal of the American Academy of Dermatology). GHK-Cu has shown upregulation of collagen and elastin genes in cell culture studies (Pickart and Margolina, 2018, Cosmetics), but human RCT data remains thin. Astaxanthin has demonstrated modest photoprotection in a randomized trial (Tominaga et al., 2012, Acta Biochimica Polonica). NMN does raise NAD+ levels in humans (Yoshino et al., 2021, Science), though whether that translates to measurable anti-aging outcomes in healthy adults is still an open question.
What did they get wrong (or right)?
The telomerase claim is the most problematic. The creator says "optimizing telomerase activity is the best way to keep your chromosomes from degrading," and attributes this to intranasal use of "Hidilon." No such compound exists in the scientific literature under that name. Telomerase activation in humans is also a genuinely double-edged area, because elevated telomerase activity is associated with certain cancers (Shay and Wright, 2011, Nature Reviews Cancer). Presenting this as a straightforward anti-aging intervention is misleading at best and potentially dangerous framing.
MT2 (Melanotan II) being listed as a photoprotective carotenoid is also wrong. MT2 is a synthetic melanocortin receptor agonist, not a carotenoid. It increases melanin production, which can reduce UV sensitivity, but it carries significant cardiovascular and hormonal side effects and is not approved for human use in most countries (Evans-Brown et al., 2009, Drug Testing and Analysis).
Where the creator does earn partial credit: the retinoid framing is directionally correct, the GHK-Cu gene transcription angle is consistent with published mechanisms, and the antioxidant section is reasonable if vague.
What should you actually know?
If you are interested in evidence-based skin aging interventions, the hierarchy of evidence matters. Tretinoin has the strongest human trial data of anything mentioned here. GHK-Cu is promising but not proven at the clinical level yet. NMN is being studied in earnest, but the anti-aging outcomes in healthy humans are not established. High-dose melatonin as an antioxidant has early mechanistic support but no long-term safety data at doses beyond standard sleep doses.
The bigger issue is the stack framing itself. Combining multiple compounds with overlapping mechanisms and unknown interaction profiles is not "biohacking," it is an uncontrolled self-experiment. Anyone considering peptide therapy should be doing so under clinical supervision, with baseline labs and monitoring, not from a 60-second TikTok.
- "Caesaretin" is not a real drug name. The creator likely means tretinoin or possibly trifarotene, but the comparison made here cannot be evaluated because the named compound does not exist in recognized literature.
- "Hidilon" does not appear in PubMed, the Merck Index, or any peptide registry this writer could find. Do not take something you cannot identify.
- MT2 is not a carotenoid and is not approved for cosmetic or therapeutic use in the US, UK, or EU.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 12 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @biomaxxer's fountain of youth peptide claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@biomaxxer's fountain of youth peptide claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
This video promotes a multi-compound anti-aging protocol combining topical retinoids, injectable or topical peptides (GHK-Cu), NAD+ precursors (NMN), carotenoids, MT2, and antioxidants.
FormBlends verdict
This video promotes a multi-compound anti-aging protocol combining topical retinoids, injectable or topical peptides (GHK-Cu), NAD+ precursors (NMN), carotenoids, MT2, and antioxidants. At least two compounds named in the video (Caesaretin, Hidilon) cannot be verified in any pharmacological or peptide database, and one compound (MT2) is mischaracterized as a carotenoid when it is a synthetic melanocortin agonist with a distinct and not fully characterized safety profile. Telomerase activation via intranasal administration of an unidentifiable compound is presented without any supporting citation and conflicts with existing oncology literature on telomerase upregulation risks.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- This video promotes a multi-compound anti-aging protocol combining topical retinoids, injectable or topical peptides (GHK-Cu), NAD+ precursors (NMN), carotenoids, MT2, and antioxidants. At least two compounds named in the video (Caesaretin, Hidilon) cannot be verified in any pharmacological or peptide database, and one compound (MT2) is mischaracterized as a carotenoid when it is a synthetic melanocortin agonist with a distinct and not fully characterized safety profile. Telomerase activation via intranasal administration of an unidentifiable compound is presented without any supporting citation and conflicts with existing oncology literature on telomerase upregulation risks.
- Tretinoin has over 30 years of RCT evidence for photoaged skin improvement, making it the most evidence-backed item in this stack (Kang et al., 1995, JAAD).
- GHK-Cu gene transcription claims are based on real published mechanisms, but human clinical trials are still sparse and no approved therapeutic indication exists.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Tretinoin has over 30 years of RCT evidence for photoaged skin improvement, making it the most evidence-backed item in this stack (Kang et al., 1995, JAAD).
- GHK-Cu gene transcription claims are based on real published mechanisms, but human clinical trials are still sparse and no approved therapeutic indication exists.
- MT2 is not a carotenoid. It is an unapproved synthetic peptide with melanocortin agonist activity and known cardiovascular side effects. Do not confuse it with astaxanthin or beta-carotene.
- NMN raises NAD+ in humans per a 2021 Science study, but translating that into measurable anti-aging outcomes in healthy adults has not been established in large-scale trials.
- Neither Caesaretin nor Hidilon can be found in any pharmaceutical or peptide database. Taking unidentifiable compounds based on social media recommendations carries serious safety risk.
- Telomerase activation is not a straightforwardly safe anti-aging target. Overactive telomerase is associated with tumor development, a fact the creator does not mention (Shay and Wright, 2011, Nature Reviews Cancer).
- Stacking multiple compounds with overlapping mechanisms and unknown interaction profiles is not a clinically validated strategy. Anyone considering peptide therapy should work with a licensed provider who can monitor labs and adjust protocols.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Biomaxxer · TikTok creator
14.0K views on this video
Highly requested video. Here’s how to acquire the fountain of youth #biohacking #supplements #skincare #antiaging #looks
Sources & references
- [1]Kang et al., 1995
- [2]Tominaga et al., 2012
- [3]Yoshino et al., 2021
- [4]Evans-Brown et al., 2009
- [5]Pickart and Margolina, 2018
- [6]Shay and Wright, 2011
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Biomaxxer, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.